New treatment of age-related macular degeneration. The Danish Society of Ophthalmology
Bloch, S.Brandi.; Larsen, M.; Haamann, P.; La Cour, M.
Ugeskrift for laeger 170(12): 1048
2008
ISSN/ISBN: 1603-6824 PMID: 18397666 Document Number: 623786
Document emailed within 1 workday
Related Documents
Sørensen, M.Sejer.; Andersen, S.; Henningsen, G.Osterby.; Larsen, C.Thornby.; Sørensen, T.Lykke. 2011: Danish version of Visual Function Questionnaire-25 and its use in age-related macular degeneration Danish Medical Bulletin 58(6): A4290Peyman, G.A.; Conway, M.D.; Recasens, M.A.; Peralta, E.; Kertes, P.J.; Greve, M.D.; El-Dessouky, E.S. 1999: Use of a macular buckle in the treatment of exudative age-related macular degeneration Ophthalmic Surgery and Lasers 30(8): 619-630
Kubicka-Trzaska, A.; Filemonowicz-Skoczek, A.; Karska-Basta, I.; Romanowska-Dixon, B. 2008: Exudative age-related macular degeneration or Best vitelliform macular dystrophy?--A case report Klinika Oczna 110(4-6): 183-187
Tommila, P. 2005: Results of age related macular degeneration treatment improved Duodecim; Laaketieteellinen Aikakauskirja 121(8): 809-810
Dimofte, D.; Danielescu, C.; Chiseliţă, D. 2010: Treatment with bevacizumab in exudative age-related macular degeneration Oftalmologia 54(2): 116-122
Haddad, W.M.; Souied, E.; Coscas, G.; Soubrane, G. 2006: Macular pigment and age-related macular degeneration. Clinical implications Bulletin de la Societe Belge d'Ophtalmologie 301: 15-22
Budzinskaia, M.V.; Pogoda, T.V.; Generozov, E.V.; Chikun, E.A.; Gurova, I.V.; Shchegoleva, I.V.; Sizova, M.V. 2013: Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration Vestnik Oftalmologii 129(5): 128-135
Korda, V.; Hejcmanová, D.; Rencová, E.; Studnicka, J.; Odrázka, K. 2005: The results of radiotherapy 24 months after treatment by patients with age-related macular degeneration Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 61(3): 166-171
Muzyka-Woźniak, M.; Oficjalska-Młyńczak, J.; Gołebiowska, B. 2008: Safety and efficacy of using bevacizumab in the treatment of exudative age-related macular degeneration Klinika Oczna 110(7-9): 280-286
Molnárová, M.; Lesková, V.; Demský, P.; Vida, R.; Izák, M. 2009: Lucentis in treatment of the wet-form of age-related macular degeneration--two years experience Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 65(5): 182-185
Chowers, I.; Pe'er, J.; Tochner, Z.; Hemo, I.; Merin, S. 1999: Radiotherapy for the treatment of choroidal neovascularization secondary to age-related macular degeneration Harefuah 136(11): 877-880
Wiggins, M.N.; Uwaydat, S.H. 2006: Age-related macular degeneration: options for earlier detection and improved treatment Journal of Family Practice 55(1): 22-27
Dolezalová, J.; Karel, I.; Hallová, H. 2010: Our two-year experience with the bevacizumab (Avastin) treatment of the age related macular degeneration wet form Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 66(1): 10-14
Falcone, P.; Chaudhry, N.A.; Grannum, E. 1998: Perifoveal laser treatment for subfoveal choroidal neovascularization in age-related macular degeneration Ophthalmic Surgery and Lasers 29(11): 933-934
Papavasileiou, E.; Zygoura, V.; Richardson, T.; Cortis, D.; Eleftheriadis, H.; Jackson, T.L. 2015: Intravitreal aflibercept (A-IVI) for the treatment of neovascular age-related macular degeneration (nv-AMD): one year experience Hellenic Journal of Nuclear Medicine 18(Suppl 1): 29-32
Studnicka, J.; Rencová, E.; Korda, V.; Hejcmanová, D.; Dusová, J.; Kvasnicka, J. 2006: Transpupillary thermotherapy in the treatment of choroidal neovascularization in age-related macular degeneration--one year's results Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 62(3): 190-199
Kolár, P.; Vizdová, D.; Vlková, E. 2006: Photodynamic therapy with visudyne in treatment of wet form of age-related macular degeneration--two years results Casopis Lekaru Ceskych 145(10): 795-800
Wykrota, H.; Gajdzik-Gajdecka, U.; Trzciakowski, K.; Smuzyńska, M. 2007: Pegaptanib sodium in treatment of choroidal neovascularization secondary to age-related macular degeneration. one year results Klinika Oczna 109(10-12): 394-401
Matušková, V.; Kolář, P.; Vysloužilová, D.; Vlková, E.; Dušek, L.; Kandrnal, V.; Jarkovský, J.; Uher, M. 2012: Ranibizumab in the ARMD wet form of age-related macular degeneration treatment - two years results obtained from the AMADEuS Registry Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 68(5): 171-177
Gonzales, C.R. 2005: Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis Retina 25(7): 815-827